CytoSorbents Announces 26th Symposium for Intensive Medicine & Intensive Care Agenda in Bremen

In ICU
Thu, 18 Feb 2016

CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced its agenda for the 26th Symposium for Intensive Medicine + Intensive Care in Bremen, Germany from February 24-26, 2016.

As the third largest conference of its kind in Europe, the meeting brings together an estimated 4,600 critical care physicians, nurses, and healthcare workers to review the most recent advances and best practices in the field. CytoSorbents will exhibit its CytoSorb® therapy for the treatment of life-threatening illnesses for the fifth consecutive year, and will also sponsor an industry satellite symposium entitled, "Systemic Inflammation and Tissue Damage – A Vicious Cycle" on February 25th from 11AM to 12:30PM.

In addition, data from the first completed investigator initiated CytoSorb® sepsis study will be presented by Dr. Sigrun Friesecke from Greifswald University, Germany, in a highly anticipated talk entitled, "CytoSorb in Patients with Refractory Septic Shock". Dr. Friesecke and her team are amongst the early pioneers of CytoSorb® usage worldwide, and have utilized it with growing success in patients with varying stages of severe sepsis and septic shock, as well as in liver dysfunction.

Source & Image Credit : Cytosorbents

«« ARDS Still Under-Recognised, Under-Treated - LUNG-SAFE Results

Kai Zacharowski Honoured by Patient Safety Foundation for PBMS »»

Critical Care, CytoSorbents, intensive care, CytoSorb

Latest Articles

Decision-Making in the ICU
- ICU Journal Article
- 19/04/2024
Decision-making in the ICU is a multifaceted process that involves clinical assessment, collaboration among multidisciplinary teams, ethical considerations, evidence-based practice, communication, and continuous adaptation to evolving clinical scenarios. Balancing the complex factors requires
READ MORE
Dealing With Uncertainty in ICU Decision-Making: A Practical Guide
- ICU Journal Article
- 19/04/2024
When the stakes are high, and the path ahead is uncertain, the decisions made, especially if a patient continues to worsen, can be sources of self-torment and can haunt us for a long time. Our goal is to suggest ways to steer decision-making for intensivists in the face of uncertainty by prop
READ MORE
The Least Bad Decision: Crisis Standards of Care After the Pandemic
- ICU Journal Article
- 19/04/2024
COVID-19 was an emergency that lasted for years and left few regions of the world untouched. The pandemic shone a spotlight on both the strengths and weaknesses of our disaster planning. What worked, what did not, and how can we better plan for future emergencies? The COVID-19 pandemic fo
READ MORE

CytoSorbents,Intensive Medicine,Intensive Care CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced its agenda for the 26th Sympo